Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
Recruiting
The purpose of this study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (ALS).
Gender:
All
Ages:
18 years and above
Trial Updated:
12/07/2023
Locations: 287, Neptune, New Jersey
Conditions: Amyotrophic Lateral Sclerosis
RAPA-501 Therapy for ALS
Recruiting
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous hybrid TREG/Th2 cells in patients living with amyotrophic lateral sclerosis (pwALS).
Gender:
All
Ages:
18 years and above
Trial Updated:
08/25/2023
Locations: Hackensack University Medical Center, Hackensack, New Jersey
Conditions: Amyotrophic Lateral Sclerosis